Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Anorexia in NSCLC
NCT04748523Completed
- Start
- Aug 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mirtazapine in anorexia nervosa (AN). Primary endpoint: Percentage of patients with Anorexia at 8 weeks. Started Aug 2018; status: completed.
02
Drugs
mirtazapine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04748523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748523.